Skip to main content

Table 2 Rates of BMD measurement, osteoporosis diagnosis, and osteoporosis medication

From: Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study

  BMD measurement (N=1,122) Osteoporosis diagnosis (N=1,122) Osteoporosis medication (N=1,122)
% P valuea % P valuea % P valuea
Total 28.2   51.5   33.0  
Age   <0.001   0.009   
 <50 9.8   17.1   0.0  
 50-64 30.3   51.6   22.3  
 ≥65 28.7   53.1   35.5  
Fracture history   <0.001   <0.001   0.53
 Yes (n=174) 38.5   65.5   36.8  
 No (n=907) 26.9   48.6   32.0  
Payment type   <0.001   <0.001   <0.001
 100% self pay 19.7   10.9   23.2  
 Partial self pay with social insurance 25.9   21.2   40.8  
 Partial self pay with private insurance 1.4   1.4   2.2  
 100% paid by social insurance 7.3   3.3   8.9  
 100% paid by private insurance 1.3   1.0   2.0  
 Hospital treatment free of charge 3.4   2.5   3.7  
 Others 11.2   9.6   14.4  
 Unknown insurance 29.7   1.6   4.7  
  1. aP-value for Fisher’s exact test.